@harry03994688 $REGN Can not resist, but if all (and much more to come) DeepMind features are incorporated into RGC-> targets#, and regn validate targets with in house mice models, license out targets to tearsty bios/pharmas, future license revenue will support just for RGC 2X current REGN MC!
@spontonic I am with patience on bdtx, just curious when will market turn around! 10K shares is bit more than few REGN shares. :-)
Resource are thin, right, but now EV is <cash. So, Sil is nothing more than burning assets, how market view them.
Thanks on GL!
$BDTX so, market still do not believe that cns-metastasis is valid approach for lung cancer drug development/approval, or that competing drugs have better results in line of: tolerability---> efficacy!
IF $REGN is measured by metrics that market measure $AAPL, what would be stock price today, and next 1-2 Q? AAPL is making 'kids toys" and REGN saving human life???
@BiotechAnalysst Adcom is political necessity not a scientifically needed input? What can penalyst contribute to general sorthage of the knowledge how to treat HD? 200 subjects at $2-4 M/per subject in trial....trail cost is +$800M, why will $QURE do this and bankrupt itself, if FDA reject BLA???
$REGN No words for E-HD pre-filled syringe timing and approval path? Once approved, HD will (may with high probability) surpassed Vabysmo in US. Bayer need to do better job in EU/World!
#Obesity, and US -way of doing business (great economy). For +40 years agricultural industry were feeding kids with high-sugar diet, now pharmaceutical industry are trying to correct it feeding them with poison that make them literally "weak" (and ugly looking)! Great! Go US!
@Biohazard3737 Yup. bread crumbs failings from the table.....sure, great way to restore confidence! We are all going to Mars! One way or another! In coffin or in incubator!
So, going forward, no true/real science from bios without tach of the "AI" (or SI) fingers! Well, we (humans) are not degrading to monkey, should be "donkey"!
@MrMojoRisinX nHCM will NEVER flay (with current drug profile), dosing ramp, test controls and REM requirement maybe work for oHCM but they fail badly for nHCM. Mizuho and a likes can stick their recommendations in their ASS!